MRM Health to Present Positive Clinical Data from MH002 in Ulcerative Colitis at Digestive Disease Week (DDW)
– Recent safety and efficacy data in both Ulcerative Colitis and Pouchitis continue to support MH002’s potential in indications characterized by mucosal... Read more.
Hunting PLC (“Hunting” or “the Company” or “the Group”) Major OCTG Order
LONDON–(BUSINESS WIRE)–Hunting secures record $145 million OCTG order from Middle East National Oil Company. Highlights Record $145 million OCTG order... Read more.
Cognite Data Fusion® Now Available on Google Cloud in Saudi Arabia
Cognite Data Fusion® on Google Cloud will bring advanced AI and machine learning tools to create actionable insights, improve operational efficiency, and drive... Read more.
Netmore Group Expands into Asia Pacific Region with Channel Focused Delivery of LoRaWAN Network Services
Platform-as-a-Service Positioned to Support Massive IoT Rollouts Across Utility, Municipal and Enterprise Markets STOCKHOLM, Sweden–(BUSINESS WIRE)–Netmore... Read more.
Hafnia Limited Announces Financial Results For The Three Months Ended March 31, 2024
SINGAPORE–(BUSINESS WIRE)–Hafnia Limited (“Hafnia”, the “Company” or “we”, OSE ticker code: “HAFNI”, NYSE ticker code “HAFN”) today... Read more.
HAFNIA LIMITED: Key information relating to dividend for the first quarter 2024
SINGAPORE–(BUSINESS WIRE)–Reference is made to the announcement made by Hafnia Limited (the “Company”) on 15 May 2024 announcing the Company’s... Read more.
Menlo Security Achieves Automotive Security Framework TISAX Certification
Successful completion of TISAX assessment brings industry-leading secure enterprise browser solution to the European automotive industry MOUNTAIN VIEW, Calif.–(BUSINESS... Read more.
Allianz Increases Operating Profit by 6.8% to 4.0 Billion Euros
Group Affirms Full-year Outlook MUNICH–(BUSINESS WIRE)–May 15, 2024 1Q 2024: Total business volume advances 5.3 percent to 48.4 billion euros Operating... Read more.
BenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected
LONDON–(BUSINESS WIRE)–BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate... Read more.
Innate Pharma Highlights Abstracts Selected for EHA 2024 Congress
Two abstracts on SAR443579 (IPH6101), ANKET® platform lead asset, a trifunctional anti-CD123 NKp46xCD16 NK cell engager under development by partner Sanofi in blood... Read more.